31
views
0
recommends
+1 Recommend
2 collections
    0
    shares

          The flagship journal of the Society for Endocrinology. Learn more

      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Differentiating between non-functioning pituitary macroadenomas and sellar meningiomas using ADC

      research-article

      Read this article at

      ScienceOpenPublisherPMC
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Introduction and aim

          It is difficult to distinguish between non-functioning pituitary macroadenomas (NFPMAs) and sellar meningiomas because of their overlapping imaging manifestations on routine MRI, especially in cases of meningiomas growing into the saddle. Here, we aimed to differentiate between these two tumors using apparent diffusion coefficient (ADC) values and MRI characteristics.

          Methods

          A total of 60 NFPMA and 52 sellar meningioma cases confirmed by the pathological analysis were retrospectively reviewed. All patients were examined via routine MRI and diffusion-weighted imaging (DWI) before undergoing surgery. The clinical characteristics, MRI characteristics, and max ADC (ADCmax), average ADC (ADCmean), and minimum ADC (ADCmin) values were compared between the two tumors via Chi-square test and two sample t-tests. Receiver operating characteristic (ROC) curve and binary logistic regression analyses were conducted to determine the discrimination ability.

          Results

          The ADCmax, ADCmean, and ADCmin values were significantly higher in NFPMAs compared to sellar meningiomas ( P < 0.001 for all). Among ADC values, ADCmax demonstrated good performance with an AUC of 0.896 (95% CI, 0.823–0.969) and accuracy of 88.7%. A cut-off value of 0.97 × 10 −3 mm 2/s was used for ADCmax for differentiation between tumors. A combination of ADCmax values and clinicoradiological features showed the best discrimination ability for differential diagnosis between the two tumors, with an AUC of 0.981 (95% CI, 0.958–1.000) and accuracy of 96.9%.

          Conclusion

          A combination of ADCmax and clinicoradiological features demonstrates good discrimination ability and high accuracy for differentiation between NFPMAs and sellar meningiomas, and is a potential quantitative tool to aid in the selection of surgical techniques.

          Related collections

          Most cited references35

          • Record: found
          • Abstract: found
          • Article: not found

          Epidemiology, clinical presentation and diagnosis of non-functioning pituitary adenomas.

          Non-functioning pituitary adenomas (NFPAs) are benign pituitary neoplasms that do not cause a hormonal hypersecretory syndrome. An improved understanding of their epidemiology, clinical presentation and diagnosis is needed.
            • Record: found
            • Abstract: found
            • Article: not found

            Pituitary magnetic resonance imaging for sellar and parasellar masses: ten-year experience in 2598 patients.

            Sellar and parasellar masses present with overlapping clinical and radiological features ranging from asymptomatic incidental presentations and hormonal effects to compressive local mass effects. Pituitary masses are diagnosed with increased frequency with magnetic resonance imaging (MRI) advancements and availability, but indications and diagnostic outcomes of MRI screening for sellar lesions are not defined. Although pituitary adenomas are the most frequently encountered sellar mass lesions, other etiologies should be considered in the differential diagnosis of a sellar mass.
              • Record: found
              • Abstract: found
              • Article: not found

              Apparent diffusion coefficient of human brain tumors at MR imaging.

              To determine if apparent diffusion coefficient (ADC) can be used to differentiate brain tumors at magnetic resonance (MR) imaging. Institutional review board approval or informed patient consent was not required. MR images were reviewed retrospectively in 275 patients with brain tumors: 147 males and 128 females 1-81 years old, treated between September 1997 and July 2003. Regions of interest were placed manually in tumor regions on MR images, and ADC was calculated with a five-point regression method at b values of 0, 250, 500, 750, and 1000 sec/mm2. ADC values were average values in tumor. All brain tumor subgroups were analyzed. Logistic discriminant analysis was performed by using ADC, age, and patient sex as independent variables to discriminate among tumor groups. A significant negative correlation existed between ADC and astrocytic tumors of World Health Organization grades 2-4 (grade 2 vs grades 3 and 4, accuracy of 91.3% [P < .01]; grade 3 vs 4, accuracy of 82.4% [P < .01]). ADC of dysembryoplastic neuroepithelial tumors (DNTs) was higher than that of astrocytic grade 2 tumors (accuracy, 100%) and other glioneuronal tumors. ADC of malignant lymphomas was lower than that of glioblastomas and metastatic tumors (accuracy, 83.6%; P < .01). ADC of primitive neuroectodermal tumors (PNETs) was lower than that of ependymomas (accuracy, 100%). ADC of meningiomas was lower than that of schwannomas (accuracy, 92.4%; P < .01). ADC of craniopharyngiomas was higher than that of pituitary adenomas (accuracy, 85.2%; P < .05). ADC of epidermoid tumors was lower than that of chordomas (accuracy, 100%). In meningiomas, ADC was not indicative of malignancy grade or histologic subtype. ADC is useful for differentiation of some human brain tumors, particularly DNT, malignant lymphomas versus glioblastomas and metastatic tumors, and ependymomas versus PNETs. Copyright RSNA, 2005.

                Author and article information

                Journal
                Endocr Connect
                Endocr Connect
                EC
                Endocrine Connections
                Bioscientifica Ltd (Bristol )
                2049-3614
                December 2020
                19 October 2020
                : 9
                : 12
                : 1233-1239
                Affiliations
                [1 ]Department of Radiology , Lanzhou University Second Hospital, Lanzhou, China
                [2 ]Key Laboratory of Medical Imaging of Gansu Province , Lanzhou, China
                [3 ]Second Clinical School , Lanzhou University, Lanzhou, China
                [4 ]Department of Pathology , Lanzhou University Second Hospital, Lanzhou, China
                Author notes
                Correspondence should be addressed to J Zhou: ery_zhoujl@ 123456lzu.edu.cn

                *(J Zhang, Z Zhao and L Dong contributed equally to this work)

                Author information
                http://orcid.org/0000-0001-8109-6347
                Article
                EC-20-0434
                10.1530/EC-20-0434
                7774768
                33112805
                2da9564d-72ce-4e3a-800d-0f8156e3db6d
                © 2020 The authors

                This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

                History
                : 14 October 2020
                : 19 October 2020
                Categories
                Research

                adc,dwi,meningiomas,mri,pituitary macroadenoma
                adc, dwi, meningiomas, mri, pituitary macroadenoma

                Comments

                Comment on this article

                Related Documents Log